SELLAS Life Sciences Group, Inc. (SLS)

2.03 +0.02 (+1.00%) USD  |  NASDAQ  |  Dec 12, 16:00
2.05 +0.02 (+0.99%) Pre-Market: 20:00
More

SELLAS Life Sciences Group Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Geron Corp. Upgrade
GT Biopharma, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade